BOTHELL, Wash.--(BUSINESS WIRE)--Lumera Corporation (Nasdaq:LMRA), an emerging leader in the field of nanotechnology, announced today that its proprietary Heterodimer Protein Technology (HPT) and ProteomicProcessor™ were both successfully used to analyze single chain antibodies from Los Alamos National Laboratory (LANL).
